The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein–coupled receptors

по Yan, Yibing, Shirakabe, Kyoko, Werb, Zena
Опубликовано 2002

Robust network inference using response logic

по Gross, Torsten, Wongchenko, Matthew J, Yan, Yibing, Blüthgen, Nils
Опубликовано в: Bioinformatics (2019)

The cancer cell proteome and transcriptome predicts sensitivity to targeted and cytotoxic drugs

по Rydenfelt, Mattias, Wongchenko, Matthew, Klinger, Bertram, Yan, Yibing, Blüthgen, Nils
Опубликовано в: Life Sci Alliance (2019)

Topological Organization Alterations of Whole-Brain Functional Networks in Patients with Childhood Absence Epilepsy: Associations with Treatment Effects

по Wang, Xueyu, Fang, Peng, Jiao, Dongmei, Hu, Tian, Yang, Qi, Liang, Wei, Li, Yijun, Yan, Yibing, Liu, Libo
Опубликовано в: Dis Markers (2021)

HSP105 Recruits Protein Phosphatase 2A To Dephosphorylate β-Catenin

по Yu, Nancy, Kakunda, Michael, Pham, Victoria, Lill, Jennie R., Du, Pan, Wongchenko, Matthew, Yan, Yibing, Firestein, Ron, Huang, XiaoDong
Опубликовано в: Mol Cell Biol (2015)

Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma

по Yan, Yibing, McArthur, Grant, Hamid, Omid, Puzanov, Igor, Gonzalez, Rene, Gajewski, Thomas, Wang, Yulei, Wongchenko, Matthew, Choong, Nicholas, Ribas, Antoni
Опубликовано 2014

Improved Cognitive Promotion through Accelerated Magnetic Stimulation

по Wu, Xingqi, Wang, Lu, Geng, Zhi, Wei, Ling, Yan, Yibing, Xie, Chengjuan, Chen, Xingui, Ji, Gong-Jun, Tian, Yanghua, Wang, Kai
Опубликовано в: eNeuro (2021)

Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice

по Carlson, Timothy R., Yan, Yibing, Wu, Xiaoqing, Lam, Michael T., Tang, Gale L., Beverly, Levi J., Messina, Louis M., Capobianco, Anthony J., Werb, Zena, Wang, Rong
Опубликовано 2005

Network quantification of EGFR signaling unveils potential for targeted combination therapy

по Klinger, Bertram, Sieber, Anja, Fritsche-Guenther, Raphaela, Witzel, Franziska, Berry, Leanne, Schumacher, Dirk, Yan, Yibing, Durek, Pawel, Merchant, Mark, Schäfer, Reinhold, Sers, Christine, Blüthgen, Nils
Опубликовано 2013

Amphiregulin and PTEN evoke a multimodal mechanism of acquired resistance to PI3K inhibition

по Edgar, Kyle A., Crocker, Lisa, Cheng, Eric, Wagle, Marie-Claire, Wongchenko, Matthew, Yan, Yibing, Wilson, Timothy R., Dompe, Nicholas, Neve, Richard M., Belvin, Marcia, Sampath, Deepak, Friedman, Lori S., Wallin, Jeffrey J.
Опубликовано 2014

Impact of depth of response on survival in patients treated with cobimetinib ± vemurafenib: pooled analysis of BRIM-2, BRIM-3, BRIM-7 and coBRIM

по Lewis, Karl D., Larkin, James, Ribas, Antoni, Flaherty, Keith T., McArthur, Grant A., Ascierto, Paolo A., Dréno, Brigitte, Yan, Yibing, Wongchenko, Matthew, McKenna, Edward, Zhu, Qian, Mun, Yong, Hauschild, Axel
Опубликовано в: Br J Cancer (2019)

Extended 5-Year Follow-Up Results of a Phase 1b Study (BRIM7) of Vemurafenib and Cobimetinib in BRAF-Mutant Melanoma

по Ribas, Antoni, Daud, Adil, Pavlick, Anna C., Gonzalez, Rene, Lewis, Karl D., Hamid, Omid, Gajewski, Thomas F., Puzanov, Igor, Wongchenko, Matthew, Rooney, Isabelle, Hsu, Jessie J., Yan, Yibing, Park, Erica, McArthur, Grant A.
Опубликовано в: Clin Cancer Res (2019)

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors

по Wilson, Timothy R., Fridlyand, Jane, Yan, Yibing, Penuel, Elicia, Burton, Luciana, Chan, Emily, Peng, Jing, Lin, Eva, Wang, Yulei, Sosman, Jeff, Ribas, Antoni, Li, Jiang, Moffat, John, Sutherlin, Daniel P., Koeppen, Hartmut, Merchant, Mark, Neve, Richard, Settleman, Jeff
Опубликовано 2012

Therapeutic resistance and susceptibility is shaped by cooperative multi-compartment tumor adaptation

по Long, Jason E., Wongchenko, Matthew J., Nickles, Dorothee, Chung, Wei-Jen, Wang, Bu-er, Riegler, Johannes, Li, Ji, Li, Qingling, Sandoval, Wendy, Eastham-Anderson, Jeff, Modrusan, Zora, Junttila, Teemu, Carano, Richard A. D., Foreman, Oded, Yan, Yibing, Junttila, Melissa R.
Опубликовано в: Cell Death Differ (2019)

Critical role for Syk in responses to vascular injury

по Andre, Patrick, Morooka, Toshifumi, Sim, Derek, Abe, Keith, Lowell, Clifford, Nanda, Nisha, Delaney, Suzanne, Siu, Gail, Yan, Yibing, Hollenbach, Stan, Pandey, Anjali, Gao, Huiyun, Wang, Yunmei, Nakajima, Kohsuke, Parikh, Sahil A., Shi, Can, Phillips, David, Owen, Whyte, Sinha, Uma, Simon, Daniel I.
Опубликовано 2011

Development of a robust flow cytometry-based pharmacodynamic assay to detect phospho-protein signals for phosphatidylinositol 3-kinase inhibitors in multiple myeloma

по Li, Congfen, Takahashi, Chikara, Zhang, Liangxuan, Huseni, Mahrukh, Stankovich, Basha, Mashhedi, Haider, Lee, Joanna, French, Dorothy, Anderson, Jeff Eastham, Kim, Doris, Howell, Kathy, Brauer, Matthew J, Kowanetz, Marcin, Yan, Yibing, Humke, Eric, Ebens, Allen, Hampton, Garret, Lackner, Mark R, Hegde, Priti, Jia, Shidong
Опубликовано 2013

Genomic features of exceptional response in vemurafenib ± cobimetinib–treated patients with BRAF(V600)-mutated metastatic melanoma

по Yan, Yibing, Wongchenko, Matthew J., Robert, Caroline, Larkin, James, Ascierto, Paolo A., Dréno, Brigitte, Maio, Michele, Garbe, Claus, Chapman, Paul B., Sosman, Jeffrey A., Shi, Zhen, Koeppen, Hartmut, Hsu, Jessie J., Chang, Ilsung, Caro, Ivor, Rooney, Isabelle, McArthur, Grant A., Ribas, Antoni
Опубликовано в: Clin Cancer Res (2019)

A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors

по Saura, Cristina, Roda, Desamparados, Roselló, Susana, Oliveira, Mafalda, Macarulla, Teresa, Pérez-Fidalgo, José Alejandro, Morales-Barrera, Rafael, Sanchis-García, Juan Manuel, Musib, Luna, Budha, Nageshwar, Zhu, Jin, Nannini, Michelle, Chan, Wai Y., Sanabria Bohórquez, Sandra M., Meng, Raymond D., Lin, Kui, Yan, Yibing, Patel, Premal, Baselga, José, Tabernero, Josep, Cervantes, Andrés
Опубликовано в: Cancer Discov (2016)

Distinct molecular profiles and immunotherapy treatment outcomes of V600E and V600K BRAF-mutant melanoma

по da Silva, Inês Pires, Wang, Kevin YX, Wilmott, James S, Holst, Jeff, Carlino, Matteo S, Park, John J, Quek, Camelia, Wongchenko, Matthew, Yan, Yibing, Mann, Graham, Johnson, Douglas B., McQuade, Jennifer L, Rai, Rajat, Kefford, Richard F, Rizos, Helen, Scolyer, Richard A, Yang, Jean YU, Long, Georgina V, Menzies, Alexander M
Опубликовано в: Clin Cancer Res (2019)

First-in-human Phase I study of Pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors

по Sarker, Debashis, Ang, Joo Ern, Baird, Richard, Kristeleit, Rebecca, Shah, Krunal, Moreno, Victor, Clarke, Paul A., Raynaud, Florence I., Levy, Gallia, Ware, Joseph A, Mazina, Kathryn, Lin, Ray, Wu, Jenny, Fredrickson, Jill, Spoerke, Jill M, Lackner, Mark R, Yan, Yibing, Friedman, Lori S., Kaye, Stan B., Derynck, Mika K., Workman, Paul, de Bono, Johann S.
Опубликовано в: Clin Cancer Res (2014)